Home / news / ONVO), ARIAD Pharmaceuticals, Inc. (NASDAQ

ONVO), ARIAD Pharmaceuticals, Inc. (NASDAQ

collected by :Rechard Bernard

follow the latest news of” market news” from different sites to most famous technicals / by 2017-01-10 at 7:40

as mentioned in

ONVO), ARIAD Pharmaceuticals, Inc. (NASDAQ

ONVO), ARIAD Pharmaceuticals, Inc. (NASDAQ*/

– Organovo Holdings, Inc. (NASDAQ:ONVO) shares ended at $3.72 with 1.12 mln shares exchanging hands.That puts the market capitalization at $398.9 mln.It opened the session with a $3.76 price tag, later ranging from $3.69 to $3.8, the range at which the stock has traded at throughout the day.
.

read more from here

Going Gangbusters – Shares Roar Higher in Session: ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA)

Going Gangbusters – Shares Roar Higher in Session: ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA)*/

– Shares of ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) are scrambling higher in today’s trading session.At the time of writing, the stock had reached $23.75.This represents a change from the opening price of -0.13%.
.

read more from here

Pre-Market Movers: ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA), Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK), VCA Inc. (NASDAQ:WOOF), Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)

Pre-Market Movers: ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA), Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK), VCA Inc. (NASDAQ:WOOF), Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)*/

– Takeda is buying Cambridge, ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) for $24 a share.The deal is valued at about $5.2 billion and expected to close in February.“This is a very exciting time for Takeda as we will broaden our hematology portfolio and transform our global solid tumor franchise through the addition of two innovative targeted therapies,” said Takeda CEO Christophe Weber in a statement.
.

read more from here

With Profitability At The Forefront, Is This Stock a Top Pick: ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA)

With Profitability At The Forefront, Is This Stock a Top Pick: ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA)*/


.

read more from here

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of ARIAD Pharmaceuticals, Inc. to Takeda Pharmaceutical Co. Ltd. for $24 Per Share is Fair to Shareholde

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of ARIAD Pharmaceuticals, Inc. to Takeda Pharmaceutical Co. Ltd. for $24 Per Share is Fair to Shareholde*/

– NEW YORK, NY / ACCESSWIRE / January 9, 2017 / The following statement is being issued by Levi & Korsinsky, LLP:To: All Persons or Entities who purchased ARIAD Pharmaceuticals, Inc. (ARIA) stock prior to January 9, 2017 .You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of ARIAD to Takeda Pharmaceutical Co. Ltd. for $24 per share.To learn more about the action and your rights, go to: http://zlk.9nl.com/ariad or contact Joseph E. Levi, Esq.
.

read more from here

read more
visit us
news

About finance market

Avatar for finance market

Check Also

U.S. Government Spends Your Tax Dollar As tax day approaches picture-12359-310x165

U.S. Government Spends Your Tax Dollar As tax day approaches

The so-called Tax March falls on April 15, the nation’s traditional deadline for submitting tax …